NICOLE TINO: Open Payments
NPI 1447533534 · MANCHESTER, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,159 in 99 payments from 17 companies in 2025. Trend: 2023 $2,439 · 2024 $2,158 · 2025 $2,159
Food & beverage: $2,159
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $391 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $244 |
| Gilead Sciences, Inc. | 10 | $239 |
| Ardelyx, Inc. | 10 | $234 |
| Madrigal Pharmaceuticals | 8 | $195 |
| QOL Medical, LLC | 4 | $161 |
| Janssen Biotech, Inc. | 8 | $158 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $151 |
| Lilly USA, LLC | 4 | $67 |
| PFIZER INC. | 3 | $64 |
Products named: XIFAXAN, IBSRELA, REZDIFFRA, Sucraid, TREMFYA, SKYRIZI, EOHILIA, CREON.
Industry payments across CT — which companies pay providers there.
